- Home
- IART
as 07-26-2024 4:00pm EST
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Upcoming Earnings Alert:
Get ready for potential market movements as Integra LifeSciences Holdings Corporation IART prepares to release earnings report on 29 Jul 2024.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 2.5B | IPO Year: | 1995 |
| Target Price: | $34.88 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Hold | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.50 | EPS Growth: | -75.73 |
| 52 Week Low/High: | $22.36 - $46.09 | Next Earning Date: | 07-29-2024 |
| Revenue: | $1,529,599,000 | Revenue Growth: | -2.07% |
| Revenue Growth (this year): | 10.86% | Revenue Growth (next year): | 5.73% |
Stock Insider Trading Activity of Integra LifeSciences Holdings Corporation (IART)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ESSIG STUART | IART | Exec. Chairman of the Board | May 23 '24 | Buy | $28.49 | 52,641 | $1,499,978.97 | 487,922 | SEC Form 4 |
| HILL BARBARA B | IART | Director | May 21 '24 | Buy | $27.40 | 36,350 | $995,815.52 | 36,350 | SEC Form 4 |
| DAVIS ROBERT T. JR. | IART | EVP & President, TT | Mar 6 '24 | Sell | $36.59 | 8,348 | $305,491.72 | 49,893 | SEC Form 4 |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Zacks
4 days ago
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Zacks
8 days ago
Implied Volatility Surging for Integra (IART) Stock Options
Simply Wall St.
9 days ago
Bullish Integra LifeSciences Holdings Insiders Loaded Up On US$2.50m Of Stock
Zacks
10 days ago
Integra's (IART) New Site to Produce Recalled Tissue Products
MT Newswires
11 days ago
Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating
MT Newswires
11 days ago
Integra LifeSciences to Shift PriMatrix, SurgiMend Production to New Braintree, Massachusetts Facility by 2026
GlobeNewswire
12 days ago
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
Compare IART vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.